These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16722635)

  • 1. New ligands with affinity for the alpha4beta2 subtype of nicotinic acetylcholine receptors. Synthesis, receptor binding, and 3D-QSAR modeling.
    Audouze K; Nielsen EØ; Olsen GM; Ahring P; Jørgensen TD; Peters D; Liljefors T; Balle T
    J Med Chem; 2006 Jun; 49(11):3159-71. PubMed ID: 16722635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
    Zhang H; Li H; Ma Q
    J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary three-dimensional quantitative structure-activity relationship modeling of binding affinity and functional potency: a study on alpha4beta2 nicotinic ligands.
    Tosco P; Ahring PK; Dyhring T; Peters D; Harpsøe K; Liljefors T; Balle T
    J Med Chem; 2009 Apr; 52(8):2311-6. PubMed ID: 19301898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computational study of the binding of 3-(arylidene) anabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein.
    Slavov SH; Radzvilovits M; LeFrancois S; Stoyanova-Slavova IB; Soti F; Kem WR; Katritzky AR
    Eur J Med Chem; 2010 Jun; 45(6):2433-46. PubMed ID: 20236734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CoMFA, CoMSIA, and molecular hologram QSAR studies of novel neuronal nAChRs ligands-open ring analogues of 3-pyridyl ether.
    Zhang H; Li H; Liu C
    J Chem Inf Model; 2005; 45(2):440-8. PubMed ID: 15807510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational evidence for the ligand selectivity to the alpha4beta2 and alpha3beta4 nicotinic acetylcholine receptors.
    Yuan H; Petukhov PA
    Bioorg Med Chem; 2006 Dec; 14(23):7936-42. PubMed ID: 16919961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisquaternary caracurine V and iso-caracurine V salts as ligands for the muscle type of nicotinic acetylcholine receptors: SAR and QSAR studies.
    Zlotos DP; Gündisch D; Ferraro S; Tilotta MC; Stiefl N; Baumann K
    Bioorg Med Chem; 2004 Dec; 12(23):6277-85. PubMed ID: 15519170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of noncompetitive inhibitors with an immobilized alpha3beta4 nicotinic acetylcholine receptor investigated by affinity chromatography, quantitative-structure activity relationship analysis, and molecular docking.
    Jozwiak K; Ravichandran S; Collins JR; Wainer IW
    J Med Chem; 2004 Jul; 47(16):4008-21. PubMed ID: 15267239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
    Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
    J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and preliminary pharmacological evaluation of new quinoline derivatives as nicotinic ligands.
    Guandalini L; Norcini M; Varani K; Pistolozzi M; Gotti C; Bazzicalupi C; Martini E; Dei S; Manetti D; Scapecchi S; Teodori E; Bertucci C; Ghelardini C; Romanelli MN
    J Med Chem; 2007 Oct; 50(20):4993-5002. PubMed ID: 17850058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group.
    Rivara S; Mor M; Bordi F; Silva C; Zuliani V; Vacondio F; Morini G; Plazzi PV; Carrupt PA; Testa B
    Drug Des Discov; 2003; 18(2-3):65-79. PubMed ID: 14675944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR modeling of mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating dopamine release.
    Zheng F; Bayram E; Sumithran SP; Ayers JT; Zhan CG; Schmitt JD; Dwoskin LP; Crooks PA
    Bioorg Med Chem; 2006 May; 14(9):3017-37. PubMed ID: 16431111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the binding mode of biarylpropylsulfonamide allosteric AMPA receptor modulators based on docking, GRID molecular interaction fields and 3D-QSAR analysis.
    Harpsøe K; Liljefors T; Balle T
    J Mol Graph Model; 2008 Jan; 26(5):874-83. PubMed ID: 17644444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New series of morpholine and 1,4-oxazepane derivatives as dopamine D4 receptor ligands: synthesis and 3D-QSAR model.
    Audouze K; Nielsen EØ; Peters D
    J Med Chem; 2004 Jun; 47(12):3089-104. PubMed ID: 15163190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel potent ligands for the central nicotinic acetylcholine receptor: synthesis, receptor binding, and 3D-QSAR analysis.
    Nielsen SF; Nielsen EO; Olsen GM; Liljefors T; Peters D
    J Med Chem; 2000 Jun; 43(11):2217-26. PubMed ID: 10841800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epiboxidine and novel-related analogues: a convenient synthetic approach and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.
    Rizzi L; Dallanoce C; Matera C; Magrone P; Pucci L; Gotti C; Clementi F; De Amici M
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4651-4. PubMed ID: 18644719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unichiral 2-(2'-pyrrolidinyl)-1,4-benzodioxanes: the 2R,2'S diastereomer of the N-methyl-7-hydroxy analogue is a potent α4β2- and α6β2-nicotinic acetylcholine receptor partial agonist.
    Bolchi C; Gotti C; Binda M; Fumagalli L; Pucci L; Pistillo F; Vistoli G; Valoti E; Pallavicini M
    J Med Chem; 2011 Nov; 54(21):7588-601. PubMed ID: 21942635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptor.
    Michielan L; Bacilieri M; Schiesaro A; Bolcato C; Pastorin G; Spalluto G; Cacciari B; Klotz KN; Kaseda C; Moro S
    J Chem Inf Model; 2008 Feb; 48(2):350-63. PubMed ID: 18215030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: synthesis of all the stereoisomers and alpha4beta2 nicotinic affinity.
    Pallavicini M; Bolchi C; Binda M; Cilia A; Clementi F; Ferrara R; Fumagalli L; Gotti C; Moretti M; Pedretti A; Vistoli G; Valoti E
    Bioorg Med Chem Lett; 2009 Feb; 19(3):854-9. PubMed ID: 19097783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.